Suppr超能文献

微小RNA-204-5p通过下调USP47和RAB22A抑制胃癌细胞增殖。

MicroRNA-204-5p inhibits gastric cancer cell proliferation by downregulating USP47 and RAB22A.

作者信息

Zhang Binbin, Yin Yuan, Hu Yaling, Zhang Jiwei, Bian Zehua, Song Mingxu, Hua Dong, Huang Zhaohui

机构信息

Oncology Institute, The Fourth Affiliated Hospital of Soochow University, The Fourth People's Hospital of Wuxi, Wuxi, 214062, Jiangsu Province, China.

出版信息

Med Oncol. 2015 Jan;32(1):331. doi: 10.1007/s12032-014-0331-y. Epub 2014 Nov 28.

Abstract

MicroRNAs (miRNAs) are a type of small noncoding RNAs that are strongly implicated in carcinogenesis. However, the potential diagnostic, prognostic and therapeutic roles of the majority of miRNAs in the pathological processes of tumorigenesis remain largely unknown. Our and others' data revealed that miR-204-5p was significantly downregulated in gastrointestinal tumor tissues compared with adjacent noncancerous tissues. The downregulation of miR-204-5p was confirmed in our gastric cancer (GC) cohort, and we showed that ectopic expression of miR-204-5p inhibited, whereas silencing miR-204-5p expression promoted GC cell proliferation in vitro. Subsequent mechanistic investigations identified that USP47 and RAB22A are direct functional targets of miR-204-5p in GC. Silencing the expression of USP47 and RAB22A using siRNA phenocopied the proliferation-inhibiting function of miR-204-5p in GC cells. Our results uncovered that miR-204-5p acts as a tumor suppressor in GC through inhibiting USP47 and RAB22A.

摘要

微小RNA(miRNA)是一类小的非编码RNA,与肿瘤发生密切相关。然而,大多数miRNA在肿瘤发生病理过程中的潜在诊断、预后及治疗作用仍 largely未知。我们及他人的数据显示,与相邻非癌组织相比,miR-204-5p在胃肠道肿瘤组织中显著下调。miR-204-5p的下调在我们的胃癌(GC)队列中得到证实,并且我们表明miR-204-5p的异位表达抑制,而沉默miR-204-5p表达促进体外GC细胞增殖。随后的机制研究确定USP47和RAB22A是GC中miR-204-5p的直接功能靶点。使用siRNA沉默USP47和RAB22A的表达模拟了miR-204-5p在GC细胞中的增殖抑制功能。我们的结果揭示,miR-204-5p通过抑制USP47和RAB22A在GC中发挥肿瘤抑制作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验